PE-backed firm with right to sell COVID-19 drug snags fresh capital
Advertisement

PE-backed firm with right to sell COVID-19 drug snags fresh capital

By Joseph Rai

  • 16 Sep 2020
Premium
PE-backed firm with right to sell COVID-19 drug snags fresh capital
Credit: Pexels

A Pune-based drugmaker that counts two private equity firms as investors and recently started selling a medicine to treat COVID-19 patients with mild to moderate symptoms has raised fresh debt capital. Brinton Pharmaceuticals Ltd, which is backed by India Alternatives and Tata Capital Healthcare Fund, has secured debt capital from non-banking ......

This is a Premium article. Please subscribe or log in to read the full story!

Here's a selection of our recent premium content.

Already a member? Click here to log in.
Advertisement
Advertisement
Google News Icon

Google News

Follow VCCircle on Google News for the latest updates on Business and Startup News